![Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy - William I Deighan, Maurice J O'Kane, Feargal P McNicholl, Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy - William I Deighan, Maurice J O'Kane, Feargal P McNicholl,](https://journals.sagepub.com/cms/10.1177/0004563216646594/asset/images/large/10.1177_0004563216646594-fig1.jpeg)
Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy - William I Deighan, Maurice J O'Kane, Feargal P McNicholl,
![Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study | JACC: CardioOncology Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study | JACC: CardioOncology](https://www.jacc.org/cms/asset/2d32c323-2cc4-4e94-bbdf-071752ae731c/fx1.jpg)
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study | JACC: CardioOncology
![Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study | Scientific Reports Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-98803-1/MediaObjects/41598_2021_98803_Fig1_HTML.png)
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study | Scientific Reports
![Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland | Future Oncology Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2023-0120/asset/images/medium/figure2.gif)
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland | Future Oncology
![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_001.jpg)